The global changes of AS prevalence, DALYs, and mortality rates of IBD among women from 1990 to 2021. by Jiefeng Zhao (9090305)

Subjects:

Estimated prevalence (A), DALYs (B), and mortality (C) rates of IBD in different age subgroups of WCBA by 2040. by Jiefeng Zhao (9090305)

Subjects:

The global changes of prevalence (A-C), DALYs (D-F), and mortality (G-I) rates of IBD among WCBA from 1990 to 2021. by Jiefeng Zhao (9090305)

Subjects:

Frontier analysis for the potential for improvement in reducing the burden of IBD among WCBA across 204 countries and regions. by Jiefeng Zhao (9090305)

Subjects:

Average stability values (mean ± standard deviation) and statistical results. by Hyung Suk Yang (20442438)

Subjects:

Stability differences between condition 1 and other conditions across participants on the non-hemiparetic side (NHP) side. by Hyung Suk Yang (20442438)

Subjects:

Individual stability values for different gait events under various conditions. by Hyung Suk Yang (20442438)

Subjects:

Dynamic stability based on the Feasible Stability Region (FSR). by Hyung Suk Yang (20442438)

Subjects:

Stability differences between condition 1 and other conditions across participants on the hemiparetic (HP) side. by Hyung Suk Yang (20442438)

Subjects:

Data Sheet 1_Comparative transcriptomics of two petal variants reveals key functional genes underlying petal shape development in lotus (Nelumbo).zip by Jiaxin He (11256475)

“…By integrating the results of morphological and enrichment analysis, key genes involved in the development of wide and narrow petal shapes in lotus were identified.</p>Results<p>It revealed that the broad petal variation of M512 was caused by a reduction in petal length while maintaining width, whereas the narrow petal phenotype of CSFY resulted from a combination of increased length and decreased width. …”

Supporting information. by Yu Sang Choi (22656230)

“…Also, the Chao1 index for richness were remarkably decreased in both MP-treated Lep KO and WT mice, but Shannon index for evenness were increased in only MP-treated Lep KO mice. …”

This is the raw data used for this study. by James M. Friedman (22522150)

Subjects:

Pre-operative versus post-operative symptoms. by James M. Friedman (22522150)

Subjects:

The Human Disharmony Loop (full) Including Inciting Factors. by James M. Friedman (22522150)

Subjects:

Baseline Severity of Disease by Scapular Dyskinesia Stage^1. by James M. Friedman (22522150)

Subjects:

The Human Disharmony Loop Clinical Presentation. by James M. Friedman (22522150)

Subjects:

Patient Demographics. by James M. Friedman (22522150)

Subjects:

Pain and Function Outcomes Following PM Tenotomy. by James M. Friedman (22522150)

Subjects:

Diagnostic Criteria for Human Disharmony Loop. by James M. Friedman (22522150)

Subjects:

Normal Anatomy vs. Disharmonic Pathoanatomy. by James M. Friedman (22522150)

Subjects: